AKER Stock UPDATES Akers Biosciences (AKER) 4.97 09/12/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 12, 2014 at 7:39 AM

Akers Biosciences (AKER) 4.97 $AKER

Police and Employers May Finally See Cannabis Breathalyzer
ACCESSWIRE - Wed Sep 10, 8:47AM CDT
Whitefish, MT / September 10, 2014 / The gradual proliferation of alcohol breathalyzer technology has helped bring down the per unit price so far that professional-grade technology, like the kind developed by Akers Biosciences, Inc. (NASDAQ: AKER), is now being marketed directly to consumers. Touted as a safety measure, as well as a means of avoiding the high cost and complications of a DUI/DWI, alcohol breathalyzers are becoming a proactive tool, used by consumers to help them more confidently enjoy an intoxicating product on their own terms.

RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Tue Sep 09, 1:34PM CDT
RedChip Companies, Inc. ("RedChip"

, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money"

TM) television program will feature three companies on Fox Business nationwide on Tuesday, September 9 at 10:00 p.m. Pacific (1 a.m. EDT). The show will also air on Bloomberg Europe on Sunday, September 14 at 8:30 a.m. and 3:30 p.m. GMT; on Bloomberg U.K. Sunday, September 14 at 5:00 p.m. and 8:30 p.m. GMT; and on Bloomberg Asia on Sunday September 14 at 3:30 p.m. HKT.

Akers Biosciences Presenting at US Investor Conferences
GlobeNewswire - Tue Sep 09, 12:43PM CDT
Executive Chairman Raymond F. Akers Jr., Ph.D, to present at:

Akers Biosciences Announces $864,000 Sales Contract for Its Rapid Results Point of Care Cholesterol Test
GlobeNewswire - Tue Sep 09, 6:30AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announced a contract valued at $864,000 for sales of its innovative Tri-Cholesterol "Check" tests in Australia, Singapore, the United Arab Emirates and Oman. The Company's products are being distributed in such regions by 36 Strategies General Trading LLC ("36S"

, a Dubai-based procurement solutions company. Target customers in Australia, Singapore, the United Arab Emirates and Oman include military forces, medical associations, universities and large companies operating in the resources sector.

RedChip Issues Research Update on Akers Biosciences
GlobeNewswire - Mon Aug 18, 9:10AM CDT
RedChip Companies, Inc., today announced it has issued a research update on Akers Biosciences Inc. (Nasdaq:AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products.

Akers Biosciences Reports Its Second Quarter Financial Results
GlobeNewswire - Tue Aug 12, 6:09AM CDT
Sales of flagship PIFA Heparin/PF4 products increasing

Akers Biosciences Announces Conference Call to Discuss Its Second Quarter and Six Months Financial Results
GlobeNewswire - Mon Aug 11, 11:17AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, will hold a conference call on Tuesday, August 12, 2014, at 10:30 a.m. Eastern Time to discuss its results for the second quarter and six months ended June 30, 2014.

Akers Appoints New Vice President of International Sales and Marketing to Build International Business
GlobeNewswire - Tue Aug 05, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces the appointment of Nicolas Daurel as Vice President of International Sales and Marketing for Europe, the Middle East and Africa ("EMEA"

. Mr. Daurel has a twenty year track-record of successfully building and managing the sales of medical devices in EMEA, particularly within the coagulation sector.

Akers Biosciences Signs Feasibility Study Deal With Konica Minolta to Develop Rapid Test to Aid Heart Attack Diagnoses
GlobeNewswire - Mon Jul 28, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, has signed a feasibility study deal with Konica Minolta, Inc. ("Konica Minolta"

to develop a rapid test for the early detection of cardiac muscle tissue damage - a condition commonly observed in patients suffering myocardial infarction (heart attacks). Heart attacks are the leading cause of death in U.S, with approximately 1.1 million Americans suffering heart attacks each year.

US Patent Granted for Akers' Breath Ketone Detection Device
GlobeNewswire - Thu Jul 17, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that the United States Patent and Trademark Office ("USPTO"

has granted a patent covering Akers' Breath Ketone detection device.

Akers to Ring Today's NASDAQ Closing Bell
GlobeNewswire - Wed Jul 09, 7:09AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce that the Company's Board of Directors, led by Raymond F. Akers Jr., Ph.D., Co-founder and Executive Chairman, will ring The NASDAQ Closing Bell this afternoon in celebration of Akers' January 23, 2014 listing on The NASDAQ Capital Market.

RedChip Issues Research Profile on Akers Biosciences
GlobeNewswire - Tue Jul 08, 9:03AM CDT
RedChip Companies, Inc., today announced it has issued a research profile on Akers Biosciences Inc. (Nasdaq:AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products.

Akers Biosciences Inc (NASDAQ: AKER) to Ring The NASDAQ Stock Market Closing Bell
GlobeNewswire - Tue Jul 08, 9:00AM CDT
What:

Akers Biosciences Signs Agreement With Medline -- a Major US Distributor
GlobeNewswire - Wed Jun 25, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces a distribution agreement (the "Agreement"

for the Company's PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests with Medline Industries Inc. ("Medline"

, the largest privately held distributor of healthcare supplies in the United States.

Akers Biosciences Announces Its Financial Results for Fiscal 2013
GlobeNewswire - Fri Mar 28, 6:00AM CDT
Akers Biosciences, Inc. (AKR.L) (Nasdaq:AKER), (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, reports its financial results for the fiscal year ended December 31, 2013.

Leading Medical Sales and Marketing Executive to Spearhead Akers Biosciences' Commercialization Strategy
GlobeNewswire - Thu Mar 27, 6:00AM CDT
Akers Biosciences, Inc. (LSE:AKR) (Nasdaq:AKER), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces the appointment of Edwin C. Hendrick as Executive Vice President, Sales and Marketing.

Akers Biosciences Co-Founder and Executive Chairman to Assume Duties of President & CEO
GlobeNewswire - Wed Mar 12, 12:15PM CDT
Akers Biosciences, Inc. (LSE:AKR) (Nasdaq:AKER), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, today announces that President and CEO Thomas A. Nicolette will be stepping down from the board and leaving the Company, effective March 28, 2014. Mr. Nicolette is the principal of Nicolette Consulting Group Limited, a business management consulting firm specializing in capital raising and financial planning. Through a series of consulting agreements, Mr. Nicolette has held the position of ABI's President since February 2007 and Chief Executive Officer since April 2008. Most recently, he played an integral role in ABI's successful listing on the NASDAQ Capital Market raising $15 million to support ABI's growth. Raymond F. Akers, Jr. PhD, the Company's Co-founder and Executive Chairman of the Board will assume the duties of President and CEO effective March 28, 2014; Mr. Nicolette will assist in the transition.

Akers Biosciences, Inc. Announces Pricing of Public Offering of Common Stock and Listing on NASDAQ
GlobeNewswire - Thu Jan 23, 12:05PM CST
Akers Biosciences, Inc. (LSE:AKR) (Nasdaq:AKER), (the "Company" or "Akers Biosciences), a leading designer and manufacturer of rapid diagnostic screening and testing products, today announced the pricing of an underwritten public offering of 2,727,000 shares (the "Shares"

of common stock at a public offering price of $5.50 per share. The shares will begin trading on The NASDAQ Capital Market on January 23, 2014 at approximately 2:10 PM EST under the symbol "AKER." The Company expects to receive approximately $15,000,000 in gross proceeds, before underwriting discounts and commissions and offering expenses payable by the Company. The Company has granted the representative of the underwriters a 45-day option to purchase up to 409,050 additional shares of common stock.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regal Intel Pursues Uncharted Territory in Rare Disease Research

New insights don't just appear out of thin air, and in the world of rare diseases, they’re often stuck behind data that’s never quite been tackled the right way. Here comes Regal Intel, a nonprofit making waves by diving into the deep end with two fresh seed grants. These folks are hell-bent on making sense of skin-deep and gut-wrenching issues that science hasn't...

Nigeria's Counterterrorism Wins: Key U.S. Partnership Gains

Sizing Up Nigeria's Latest Counterterrorism Strides Eyeballing Nigeria these days, it’s turning into quite the action-packed saga of counterterrorism success. President Bola Tinubu's administration, bolstered by a gritty partnership with Trump’s legacy and the ongoing U.S. military collaboration, has been making waves in curbing terrorism within its borders. This...

Newsday Unveils Essential Guide to NY Colleges

Launching a Comprehensive College Resource Ah, the college decision stress. Back in the day it was simpler, just pick a campus that looked good on paper and hope for the best. But now? Kids and their families have got a minefield of information to navigate. Time to make room at the table for Newsday's latest attempt to unravel the college chaos with their Essential Guide...

TIGR Investors Eye Class Action Amid Legal Woes

A Legal Storm Brews Over UP Fintech When it rains, it pours, and for UP Fintech Holding Limited, the sky's looking pretty stormy. Investors who jumped on the NASDAQ:TIGR bandwagon between April 2024 and June 2026 are finding themselves at the center of a nasty legal maelstrom. The allegations? Well, they're explosive, hinting at a pattern of unlicensed cross-border...

Unlock Ingenuity Hits Georgia: Homeowners Rejoice

A Game-Changer for Georgia Homeowners Georgia, your ship might just have come in. The Unlock Home Equity Agreement (HEA) has cornered the market by letting homeowners dip into their home's cash pool without touching their wallets for monthly payments. This means cash in your hands now, in exchange for a share of the home's future value when you decide to wrap it up. It's...

LinkSquares Dominates LegalTech with Innovative AI

AI-Powered Legal Giant Gets Recognition Ah, the legal world—one of those industries that feels like it’s crawling at a snail’s pace, yet it’s where solidity and caution are prized above all else. But every so often, something like LinkSquares comes around and throws a wrench into the old routine, shaking things up in a big way. Crammed full of Agentic AI—sounds...

MY DR NOW Challenges 9-to-5 with New Clinics

Revolutionizing Healthcare Access Latte in one hand and the other hand tapping your steering wheel, trying to squeeze in that elusive doctor’s appointment between work meetings. Sound familiar? Well, those days might just be numbered. MY DR NOW is shaking up the traditional 9-to-5 doctor’s office stereotype by opening two new clinics that’ll stand sentinel seven...

UN Urges Real Progress on Climate at COP31 Summit

When it comes to global climate action, meetings like the COP31 summit aren’t just another day in the office. Today, in Antalya, Türkiye, the talk was big, but the stakes are even bigger as business and UN leaders grappled with the nagging gap between corporate commitments and actual emissions reductions. The Urgency of 1.5°C Folks, we're skating on thin ice here with...

AiPrise Token Sharing Streamlines Compliance Tasks

Streamlining the Redundant Chore of Compliance Now, here's something with teeth. AiPrise rolls out its Token Sharing infrastructure, a crafty solution to a common hassle—duplicated compliance work. It's a game changer for financial institutions that find themselves drowning in a sea of repetitive verification tasks. The notion of sharing verified customer data among...

Health In Tech's Rocky Q3: Navigating Losses and Opportunities

Signs of Optimism Amidst Financial Struggles Health In Tech is wading through the choppy waters of its Q3 2026 financial results—revenue came in at $6.6 million, down from $8.5 million the previous year. Seems like their investments are all geared up, but the sails aren’t quite catching wind yet. That said, their contracted revenue strutted to $32.7 million for the...